Table 2. Mean time intervals between visits for patients with CRVO or BRVO treated with ranibizumab injection or dexamethasone implant who had 12 months of follow-up data.

Time interval between visits, days	CRVO (n=1369)			BRVO (n=1818)
	Ranibizumab injection	Dexamethasone implant		Ranibizumab injection	Dexamethasone implant
	(n=1178)	(n=191)	P-value	(n=1644)	(n=174)	P-value
All ophthalmology visits	46.8 (26.0)	55.3 (38.2)	<0.0001	47.8 (25.2)	59.6 (33.2)	<0.0001
Treatment visits	61.7 (42.9)	159.0 (71.1)	<0.0001	63.2 (43.3)	162.1 (72.2)	<0.0001
Non-treatment visits	77.4 (50.4)	66.9 (38.9)	0.009	75.8 (43.7)	74.6 (44.1)	0.702

Abbreviations: BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion; SD, standard deviation.

Data are shown as mean (SD).